A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2006
12/27/2006	CN1883608A Medicine for treating tragomaschalia
12/27/2006	CN1883606A A medicine with longan seeds for treating tragomaschalia
12/27/2006	CN1883578A Medicine for treating tragomaschalia by minium
12/27/2006	CN1883577A Medicine for treating tragomaschalia
12/27/2006	CN1883573A Chinese medicinal preparation for treating finger tip injury
12/27/2006	CN1883568A Chinese medicinal ointment for treating beriberi
12/27/2006	CN1883566A Anti-inflammation medicine and method for preparing same
12/27/2006	CN1883558A Medicinal powder for treating tragomaschalia
12/27/2006	CN1883555A A medicine for treating beriberi
12/27/2006	CN1883551A A medicinal powder for treating tragomaschalia
12/27/2006	CN1883550A A medicine for treating dermatosis
12/27/2006	CN1883547A A hicismus-treating medicine with creat
12/27/2006	CN1883531A A medicinal powder with climbing groundsel for treating hicismus
12/27/2006	CN1883519A A botanical drug for treating psoriasis and preparation process of its crude drug abietic acid
12/27/2006	CN1883487A Powder placed inside shoes for treating foot odor and beriberi
12/27/2006	CN1883485A A gel for treating chronic cutaneous pruritus and preparation method thereof
12/27/2006	CN1883475A Compound teribinafine hydrochloride solution for animal
12/27/2006	CN1883444A Application of paeonol in preparation of whitening and freckle-removing cosmetic or pigmentation disease-treating medicine
12/27/2006	CN1883275A A botanical antibiotic and application thereof
12/27/2006	CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/27/2006	CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006	CN1291752C External applied Chinese medicinal composition for treating psora and its preparation method
12/27/2006	CN1291734C Quality control method of Chinese medicinal soft capsule
12/27/2006	CN1291732C Externally applied scouring liquor for alphos
12/27/2006	CN1291717C Antipruritic
12/26/2006	US7153997 N-hydroxyphenoxyphenyl derivatives of glycine or valine, e.g., N-[3,5-Dichloro-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)benzoyl]glycine; treating metabolic disorders or diseases dependent upon the expression of a T3 regulated gene
12/26/2006	US7153963 Phenylalanine derivatives
12/26/2006	US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006	US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006	US7153862 αv integrin receptor antagonists
12/26/2006	US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006	US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis
12/26/2006	US7153830 Administering factor XIII systemically optionally in conjunction with activated thrombin.
12/26/2006	US7153826 Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
12/26/2006	US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes
12/26/2006	US7153822 Compositions and methods for modulating connexin hemichannels
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153492 prophylactic or wound-healing treatment of lactating animals prone to develop or suffering from mastitis; chitosan, its derivatives and salts thereof and a second component capable of releasing CO2 in an acidic environment
12/21/2006	WO2006135027A1 Agent for treatment of wound and/or promotion of wound healing
12/21/2006	WO2006134970A1 Coenzyme q10-containing water-soluble composition and process for production thereof
12/21/2006	WO2006134963A1 Agent for fibrous disease comprising oxaluric acid derivtive
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134937A1 Skin preparation for external use
12/21/2006	WO2006134890A1 Composition for protection of body surface
12/21/2006	WO2006134279A2 Method for solubilizing metronidazole
12/21/2006	WO2006134146A1 Orthopaedic skeletal demonstration aids
12/21/2006	WO2006133829A2 Use of 25-hydroxy-vitamin d3
12/21/2006	WO2006133784A1 Use of substituted piperazine derivatives and morpholine derivatives
12/21/2006	WO2006133506A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
12/21/2006	WO2006133498A1 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-{[(1s)-1-pyridin-3-ylbutyi]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof
12/21/2006	WO2006117885A8 External preparation for skin
12/21/2006	WO2006069154A3 Vitamin d receptor modulators
12/21/2006	WO2006058303A3 Modulators of muscarinic receptors
12/21/2006	WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
12/21/2006	US20060287632 Oxygen producing device for woundcare
12/21/2006	US20060287536 Phenyl-thiophene type vitamin d receptor modulators
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases
12/21/2006	US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
12/21/2006	US20060287277 water soluble, microparticulates; bone injuries
12/21/2006	US20060287268 Splice-region antisense composition and method
12/21/2006	US20060286157 Protein mixtures for wound healing
12/21/2006	US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	DE202006012266U1 Natural healing and care oil, useful e.g. for treating wounds, joint pain and rheumatism, comprises extra virgin olive oil and tincture of propolis
12/21/2006	CA2611883A1 Method for solubilizing metronidazole
12/21/2006	CA2611831A1 A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1733741A2 O/W-emulsions comprising one or several bioquinones and an elevated amount of glycerine
12/20/2006	EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006	EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase
12/20/2006	EP1733724A1 Amino alcohol compound
12/20/2006	EP1732921A1 Thioamide derivatives as progesterone receptor modulators
12/20/2006	EP1732648A2 Treatment of diseases
12/20/2006	EP1732593A1 Use of epi-hne 1-4
12/20/2006	EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis
12/20/2006	EP1732542A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/20/2006	EP1506200B1 Diazabicyclic biaryl derivatives
12/20/2006	EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors
12/20/2006	EP1427440B1 Use of plasminogen for promoting healing of tympanic membrane perforation
12/20/2006	EP1401809B1 Tryptase inhibitors
12/20/2006	EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006	EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
12/20/2006	CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/20/2006	CN1882350A Method for controlling angiogenesis in animals
12/20/2006	CN1882341A Method and composition for treatment of cutaneous lesions
12/20/2006	CN1882310A 化妆品组合物 Cosmetic composition
12/20/2006	CN1880343A Chemically modified polyaminosaccharide by a hydrocarbyl sultone compound
12/20/2006	CN1880334A High purity albumin production process
12/20/2006	CN1879883A Preparation method of medicine for treating male baldness and its clinical application
12/20/2006	CN1879882A Combine injection formulation
12/20/2006	CN1879873A Medicine for treating alopecia areata and its preparing method
12/20/2006	CN1879863A Dew for treating tragomaschalia

1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 1065